Biosensing for organ-on-a-chip platforms

组织工程和微流体技术的最新进展使得“芯片上的器官”平台能够比传统的培养皿细胞培养系统更好地模拟人体器官和组织的功能。这些技术在疾病建模、药物发现以及作为生物反应器试验台开发工程组织方面具有很大的前景。尽管具有巨大的潜力，但芯片上器官和微流体细胞培养平台的一个持续的局限性是它们依赖于人工的、芯片外的分析方法，这造成了分析瓶颈，限制了这些平台的价值。集成片上传感可以实现更高通量和更高含量的分析，实时测量细胞和组织功能，甚至动态培养微系统的反馈控制。引人注目的是，虽然在将生物传感器集成到即时微流控设备方面取得了重大进展，但生物传感器尚未集成到微组织和器官芯片平台上，主要是因为涉及到工程挑战。

Recent advances in tissue engineering and microfluidics have enabled the creation of “organ-on-a-chip” platforms that mimic the functions of human organs and tissues better than conventional Petri dish-based cell culture systems. These technologies hold great promise for disease modeling, drug discovery, and as bioreactor test beds to develop engineered tissues. Despite their great potential, a persistent limitation of organ-on-a-chip and microfluidic cell culture platforms is that they rely on manual, off-chip analytical methods, which creates an analysis bottleneck and limits the value of these platforms. Integration of on-chip sensing could enable higher-throughput and higher-content analyses, real-time measurement of cell and tissue function, and even feedback control of dynamic culture microsystems. Strikingly, while there have been significant advances in incorporating biosensors into point-of-care microfluidic devices, biosensors have not been integrated into microtissue and organ-on-a-chip platforms largely because of the engineering challenges involved.